Search Results

Weighing Evidence Quality in Interventional Oncology

The importance of understanding the levels of evidence related to IO therapies and areas for future research.

By Derek Biederman, MD, and Edward Kim, MD

Urgent-Start Peritoneal Dialysis: Patient Selection and Procedural Considerations

An interventional radiologist’s guide to placement of urgent peritoneal dialysis catheters, an efficient, cost-effective, minimally invasive alternative to traditional surgical placement.

By Ahmed K. Abdel-Aal, MD, PhD; Mohamed Shahin, MD, PhD, MBA; Shahroz K. Aziz, MD; Husameddin M. El Khudari, MD; and Ammar Almehmi, MD, MPH

Brain Tumors, Interventionists, and Radiation: How Real Is the Risk?

Weighing the available evidence on dosimetry, epidemiologic data, and cellular and vascular effects to evaluate risk.

By Rebecca M. Marsh, PhD, and Michael Silosky, MS

Renal Ablation: Can We Push the Treatment Boundaries?

Strategies for treatment based on size criteria, ablation modality, tumor location, periprocedural considerations, and combination therapy options.

By Ronak Patel, BS, and Merve Ozen, MD

cTACE: The Rebirth of Lipiodol?

Lipiodol-based cTACE remains the most well-studied transarterial therapy for hepatocellular carcinoma.

By Ali Kord Valeshabad, MD, MPH; Jeffrey Kuwahara, MD; and Charles E. Ray Jr, MD, PhD, MS

An Interview With Nadine Abi-Jaoudeh, MD, FSIR

Dr. Abi-Jaoudeh discusses her endeavors in the HCC trial landscape, research consensus panels with the SIR Foundation, tips for fostering DEI as an institutional leader, and more.

PAE: Factors That Will Influence Widespread Acceptance

A look at the current position of PAE and the opportunities and challenges of establishing its role in the treatment pathway for symptomatic benign prostatic hyperplasia.

By Timothy J.C. Bryant, BMedSci, BMBS, MRCP, FRCR

Optimal Landing Zone for TEVAR

Considerations regarding landing zone length and diameter, angulation, and calcification and thrombus and a review of available devices.

By Kyle Reynolds, MD, and Javairiah Fatima, MD, FACS, RPVI, DFSVS

Ablation Modalities in Interventional Oncology

A summary of the techniques, advantages, and future applications of available ablation options.

By Govindarajan Narayanan, MD; Raihan Noman, MD; Uchechukwu Uzomah, MD; and Ripal T. Gandhi, MD

Interventional Treatment Options for Vascular Malformations

Approaches, techniques, and sclerosing and embolic agents that can be used in low- and high-flow vascular malformations.

By Guilherme Dabus, MD, and James F. Benenati, MD

Combination Locoregional and Immunotherapy in Practice

Beau B. Toskich, MD, leads Rony Avritscher, MD; Kirema Garcia-Reyes, MD; and Nora Tabori, MD, through a series of questions about their approaches to combining local therapy with immunotherapy, how/if recent data have impacted their decision-making, preferences on type of immunotherapy, emerging applications, and more.

Treatment Options for Cerebral AVMs and Dural AVFs

The second of a three-part series on diagnosing, treating, and researching management options for intracranial malformations.

By Lyahn K. Hwang, BS; Vivek A. Kumar, PhD; Ravi R. Vissapragada, MD; Karen Y. Lui, MD; Matthew R. Fusco, MD; Christopher S. Ogilvy, MD; and Ajith J. Thomas, MD

Multimodality Imaging and Image-Guided Surgery

Advances in imaging provide physicians with the confidence to confront procedures previously thought impossible.

By Vikash R. Goel, MS; Anil Ambekar, MD; and Roy K. Greenberg, MD

Year in Review: Top Papers in Interventional Oncology

An overview of significant interventional oncology articles published in the recent literature and summaries of the potential impact each may have on the field.

By Ammar Sarwar, MD, FSIR, and Suvranu Ganguli, MD, FSIR

Essential Innovation and Clinical Trial Needs in Vascular Care

Experts from a variety of specialty backgrounds comment on hurdles and opportunities for future clinical trials to explore.

With Kendal M. Endicott, MD; Jessica P. Simons, MD, MPH; Abinaya Ramakrishnan, BA; Salma Youssef; Mona Ranade, MD; John M. Moriarty, MD, FSIR; Peter A. Schneider, MD; Amy C. Taylor, MD; Sarah B. White, MD, MS, FSIR, FCIRSE; Stephen A. Black, MD, FRCS(Ed), FEBVS; Kunal P. Raygor, MD; Mehdi Bouslama, MD, MSc; and Elad I. Levy, MD, MBA

BCLC Staging and Treatment Algorithm: Does It Cover All?

The Barcelona Clinic Liver Cancer staging system is a commonly used algorithm for the management of HCC; however, there are key deviations in contemporary practice.

By Altan Ahmed, MD, MSc; Richard Kim, MD; Daniel A. Anaya, MD, MSHCT, FACS; and Bela Kis, MD, PhD, FSIR

Optimizing Anti-Thrombotic Therapy After Catheter-Directed Interventions for DVT and PTS

Recommendations for anti-thrombotic and anti-inflammatory regimens after deep venous disease interventions based on patient presentation, comorbidities, and type of intervention.

By Dhara Kinariwala, MD; Aditya M. Sharma, MD, RPVI, FSVM; and Minhaj S. Khaja, MD, MBA, FSIR, FSVM

Intentional False Lumen Thrombosis After Aortic Dissection

The best strategies for thrombosing the false lumen, how to execute various techniques, and intervention timing.

By Konstantinos Spanos, MD, MSc, PhD; Fiona Rohlffs, MD; Nikolaos Tsilimparis, MD, PhD; and Tilo Kölbel, MD, PhD